1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue

1.5 Market Analysis by Type

1.5.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Monotherapy

1.5.3 Combination Therapy

1.6 Market by Application

1.6.1 Global Neoantigen Targeted Therapies Market Share by Application: 2022-2027

1.6.2 Medical Research Institution

1.6.3 Hospital and Clinic

1.6.4 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Neoantigen Targeted Therapies Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porters Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Neoantigen Targeted Therapies Market Players Profiles

3.1 Bavarian Nordic

3.1.1 Bavarian Nordic Company Profile

3.1.2 Bavarian Nordic Neoantigen Targeted Therapies Product Specification

3.1.3 Bavarian Nordic Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Neon Therapeutics

3.2.1 Neon Therapeutics Company Profile

3.2.2 Neon Therapeutics Neoantigen Targeted Therapies Product Specification

3.2.3 Neon Therapeutics Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Immunicum

3.3.1 Immunicum Company Profile

3.3.2 Immunicum Neoantigen Targeted Therapies Product Specification

3.3.3 Immunicum Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Genocea Biosciences

3.4.1 Genocea Biosciences Company Profile

3.4.2 Genocea Biosciences Neoantigen Targeted Therapies Product Specification

3.4.3 Genocea Biosciences Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 MediGene

3.5.1 MediGene Company Profile

3.5.2 MediGene Neoantigen Targeted Therapies Product Specification

3.5.3 MediGene Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Gradalis

3.6.1 Gradalis Company Profile

3.6.2 Gradalis Neoantigen Targeted Therapies Product Specification

3.6.3 Gradalis Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Iovance Biotherapeutics

3.7.1 Iovance Biotherapeutics Company Profile

3.7.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Product Specification

3.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Immunovative Therapies

3.8.1 Immunovative Therapies Company Profile

3.8.2 Immunovative Therapies Neoantigen Targeted Therapies Product Specification

3.8.3 Immunovative Therapies Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Neoantigen Targeted Therapies Market Competition by Market Players

4.1 Global Neoantigen Targeted Therapies Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Neoantigen Targeted Therapies Revenue Market Share by Market Players (2016-2021)

4.3 Global Neoantigen Targeted Therapies Average Price by Market Players (2016-2021)

5 Global Neoantigen Targeted Therapies Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Neoantigen Targeted Therapies Market Size (2016-2021)

5.1.2 Neoantigen Targeted Therapies Key Players in North America (2016-2021)

5.1.3 North America Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.1.4 North America Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Neoantigen Targeted Therapies Market Size (2016-2021)

5.2.2 Neoantigen Targeted Therapies Key Players in East Asia (2016-2021)

5.2.3 East Asia Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.2.4 East Asia Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Neoantigen Targeted Therapies Market Size (2016-2021)

5.3.2 Neoantigen Targeted Therapies Key Players in Europe (2016-2021)

5.3.3 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.3.4 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Neoantigen Targeted Therapies Market Size (2016-2021)

5.4.2 Neoantigen Targeted Therapies Key Players in South Asia (2016-2021)

5.4.3 South Asia Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.4.4 South Asia Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Neoantigen Targeted Therapies Market Size (2016-2021)

5.5.2 Neoantigen Targeted Therapies Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.5.4 Southeast Asia Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Neoantigen Targeted Therapies Market Size (2016-2021)

5.6.2 Neoantigen Targeted Therapies Key Players in Middle East (2016-2021)

5.6.3 Middle East Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.6.4 Middle East Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Neoantigen Targeted Therapies Market Size (2016-2021)

5.7.2 Neoantigen Targeted Therapies Key Players in Africa (2016-2021)

5.7.3 Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.7.4 Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Neoantigen Targeted Therapies Market Size (2016-2021)

5.8.2 Neoantigen Targeted Therapies Key Players in Oceania (2016-2021)

5.8.3 Oceania Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.8.4 Oceania Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Neoantigen Targeted Therapies Market Size (2016-2021)

5.9.2 Neoantigen Targeted Therapies Key Players in South America (2016-2021)

5.9.3 South America Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.9.4 South America Neoantigen Targeted Therapies Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Neoantigen Targeted Therapies Market Size (2016-2021)

5.10.2 Neoantigen Targeted Therapies Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Neoantigen Targeted Therapies Market Size by Type (2016-2021)

5.10.4 Rest of the World Neoantigen Targeted Therapies Market Size by Application (2016-2021)

6 Global Neoantigen Targeted Therapies Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Neoantigen Targeted Therapies Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Neoantigen Targeted Therapies Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Neoantigen Targeted Therapies Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Neoantigen Targeted Therapies Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Neoantigen Targeted Therapies Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Neoantigen Targeted Therapies Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Neoantigen Targeted Therapies Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Neoantigen Targeted Therapies Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Neoantigen Targeted Therapies Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Neoantigen Targeted Therapies Consumption by Countries

7 Global Neoantigen Targeted Therapies Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Neoantigen Targeted Therapies (2022-2027)

7.2 Global Forecasted Revenue of Neoantigen Targeted Therapies (2022-2027)

7.3 Global Forecasted Price of Neoantigen Targeted Therapies (2022-2027)

7.4 Global Forecasted Production of Neoantigen Targeted Therapies by Region (2022-2027)

7.4.1 North America Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.3 Europe Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.7 Africa Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.9 South America Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Neoantigen Targeted Therapies Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Neoantigen Targeted Therapies by Application (2022-2027)

8 Global Neoantigen Targeted Therapies Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.2 East Asia Market Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.3 Europe Market Forecasted Consumption of Neoantigen Targeted Therapies by Countriy

8.4 South Asia Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.5 Southeast Asia Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.6 Middle East Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.7 Africa Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.8 Oceania Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.9 South America Forecasted Consumption of Neoantigen Targeted Therapies by Country

8.10 Rest of the world Forecasted Consumption of Neoantigen Targeted Therapies by Country

9 Global Neoantigen Targeted Therapies Sales by Type (2016-2027)

9.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2016-2021)

9.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027)

10 Global Neoantigen Targeted Therapies Consumption by Application (2016-2027)

10.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2016-2021)

10.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027)

11 Global Neoantigen Targeted Therapies Manufacturing Cost Analysis

11.1 Neoantigen Targeted Therapies Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Neoantigen Targeted Therapies

12 Global Neoantigen Targeted Therapies Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Neoantigen Targeted Therapies Distributors List

12.3 Neoantigen Targeted Therapies Customers

12.4 Neoantigen Targeted Therapies Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer